TOPOISOMERASE INHIBITORS ENHANCE THE CYTOCIDAL EFFECT OF AAV-HSVTK/GANCICLOVIR ON CANCER CELLS

腺相关病毒（AAV）是具有单链DNA基因组的非致病性病毒。AAV载体具有适合基因治疗应用的几个独特特性。然而，其应用的一个障碍是转基因表达效率低，主要是由于第二链合成有限。在本研究中，我们研究了拓扑异构酶抑制剂（依托泊苷和喜树碱）是否能增强AAV载体介导的转基因表达和AAVtk/GCV系统的杀伤效果。在人喉癌细胞（HEp-2细胞）和HeLa细胞中观察到转基因表达呈浓度依赖性增强。Southern分析证实依托opo苷增强了HEp-2细胞和HeLa细胞中AAV载体基因组的双链合成。AAVtk/GCV系统有效杀伤细胞。更重要的是，依托茶苷和喜树碱都增强了AAVtk/GCV系统的杀细胞作用。在体外实验的基础上，我们评估了AAV载体在裸鼠皮下接种HEp-2后的转基因表达和抗肿瘤活性。与AAVtk/GCV、AAVtk/PBS等对照相比，在异种移植肿瘤中观察到LacZ的表达，并且AAVtk/GCV系统抑制肿瘤的生长。这些发现表明，aav介导的自杀基因治疗与拓扑异构酶抑制剂治疗的结合可能在癌症治疗中具有协同治疗作用。

Adeno-associated virus(AAV) is a nonpathogenic virus with a single-strand DNA genome. AAV vectors have several unique properties suited for gene therapy applications. However, an obstacle to their application is a low efficiency of transgene expression, mainly due to a limited second-strand synthesis. In the present study, we investigated whether topoisomerase inhibitors (etoposide and camptothecin) enhance the AAV vector-mediated transgene expression and the killing effect by AAVtk/GCV system. The enhancement of transgene expression was observed in a concentration-dependent manner on human laryngeal carcinoma cells (HEp-2 cells) and HeLa cells. Southern analysis confirmed that etoposide enhanced the double-strand synthesis of the AAV vector genome in HEp-2 cells and HeLa cells. The cells were efficiently killed by AAVtk/GCV system, as expected. More importantly, both etoposide and camptothecin augmented the cytocidal effect of the AAVtk/GCV system. Following the in vitro experiments, we evaluated the transgene expression and the antitumor activity of the AAV vectors in nude mice inoculated with HEp-2 subcutaneously. The LacZ expression was observed in the xenografted tumors and the AAVtk/GCV system suppressed the tumors growth compared with any other control such as AAVLacZ/GCV, AAVtk/PBS. These findings suggest that the combination of AAV-mediated suicide gene therapy and treatment with topoisomerase inhibitors may have synergistic therapeutic effects in the treatment of cancers.